The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Tarasov R.S.

State Research Institute for Complex Issues of Cardiovascular Diseases Municipal Budget Healthcare Institution, Kemerovo, Russia

Bakovsky K.V.

Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia

Acute coronary syndrome for patients with prior coronary artery bypass grafting: current state of the matter

Authors:

Tarasov R.S., Bakovsky K.V.

More about the authors

Journal: Russian Cardiology Bulletin. 2018;13(4): 57‑61

Read: 2015 times


To cite this article:

Tarasov RS, Bakovsky KV. Acute coronary syndrome for patients with prior coronary artery bypass grafting: current state of the matter. Russian Cardiology Bulletin. 2018;13(4):57‑61. (In Russ.)
https://doi.org/10.17116/Cardiobulletin20181304157

Recommended articles:
Prognostic role of frailty in early and long-term prognosis after coro­nary artery bypass grafting. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(5):512-518
Left ante­rior descending artery and diagonal branch bypass in multiple-vessel coro­nary artery disease. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(6):646-650

References:

  1. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, et al. NRMI Investigators. Coronary bypass graft fate and patient outcome: angiograÂphic follow- up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol. 1996;28:616-626.
  2. Van der Heijden LC, Kok MM, Zocca P, Sen H, et al. Long-Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer-Generation Drug-Eluting Stents. J Am Heart Assoc. 2018;7(3). pii: e007212.
  3. Nikolsky E, Mehran R, Ohman EM, Bertrand ME, Lincoff AM, et al. Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: analysis from the ACUITY trial. J Am Coll Cardiol. 2010;55:190-1777.
  4. Al-Aqeedi R, Asaad N, Al-Qahtani A, et al. Acute coronary syndrome in patients with prior coronary artery bypass surgery: observations from a 20-year registry in a middle-eastern country. PLoS ONE. 2012;7:e40571.
  5. Nikolsky E, McLaurin BT, Cox DA, Manoukian SV, Xu K, Mehran R, Stone GW. Outcomes of patients with prior coronary artery bypass grafting and acute coronary syndromes: analysis from the ACUITY (acute catheterization and urgent intervention triage strategy) trial. J Am Coll Cardiol Interv. 2012;5:919-926. https://journals.plos.org/plosone/article/authors?id=10.1371/journal.pone.0040571
  6. Alanbaei M, Alsheikh-Ali AA, Aleinati T, Zubaid M, Ridha M, et al. Clinical characteristics and outcomes of patients with acute coronary syndrome and prior coronary artery bypass grafting in a large middle eastern cohort. Open Cardiovasc Med J. 2011;5:196-202.
  7. Hong MK, Mehran R, Dangas G, et al. Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results. J Am Coll Cardiol. 2001;38:150-154.
  8. Morrison DA, Sethi G, Sacks J, et al. Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients. J Am Coll Cardiol. 2002;40:1951-1954.
  9. Webb LA, Dixon SR, Safian RD, O’Neill WW. Usefulness of embolic protection devices during saphenous vein graft intervention in a non-selected population. J Interv Cardiol. 2005;18(2):73-75.
  10. Abdel-Karim AR, Da Silva M, Lichtenwalter C. Prevalence and outcomes of intermediate saphenous vein graft lesions: findings from the stenting of saphenous vein grafts randomized-controlled trial. Int J Cardiol. 2013;168(3):2468-2473.
  11. Halabi AR, Alexander JH, Shaw LK, et al. Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery. Am J Cardiol. 2005;96:1254-1259.
  12. Bryan AJ, Angelini GD. The biology of saphenous vein graft occlusion: etioÂlogy and strategies for prevention. Curr Opin Cardiol. 1994;9:641-649.
  13. Bourassa MG, Campeau L, Lesperance J, Grondin CM. Changes in grafts and coronary arteries after saphenous vein aortocoronary bypass surgery: results at repeat angiography. Circulation. 1982;65:90-97.
  14. Rosenfeldt FL, He GW, Buxton BF, Angus JA. Pharmacology of coronary artery bypass grafts. Ann Thorac Surg. 1999;67:878-888.
  15. Tsui JC, Dashwood MR. Recent strategies to reduce vein graft occlusion: a need to limit the effect of vascular damage. Eur J Vasc Endovasc Surg. 2002;23:202-208.
  16. Barboriak JJ, Pintar K, Van Horn DL, Batayias GE, Korns ME. PatholoÂgic findings in the aortocoronary vein grafts. A scanning electron microscope study. Atherosclerosis. 1978;29:69-80.
  17. Waksman R, Koifman E. Embolic protection device for saphenous vein graft intervention: too early to take off the seat belt. Circ Cardiovasc Interv. 2015; 8(3):e002371.
  18. Domanski MJ, Borkowf CB, Campeau L, et al. Prognostic factors for atherosclerosis progression in saphenous vein grafts: the postcoronary artery bypass graft (Post-CABG) trial. Post-CABG Trial Investigators. J Am Coll Cardiol. 2000;36:1877-1883.
  19. Nwasokwa ON. Coronary artery bypass graft disease. Ann Intern Med. 1995;123:528-545.
  20. Zavalloni D, Rossi ML, Scatturin M, et al. Drug-eluting stents for the percutaneous treatment of the anastomosis of the left internal mammary graft to left anterior descending artery. Coron Artery Dis. 2007;18:495-500.
  21. Zhou Q, Liao JK. Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy. Curr Pharm Des. 2009;15:467-478.
  22. Hermiller JB, Tenaglia AN, Kisslo KB, et al. In vivo validation of compensatory enlargement of atherosclerotic coronary arteries. Am J Cardiol. 1993;71:665-668.
  23. Panetta TF, Marin ML, Veith FJ, et al. Unsuspected preexisting saphenous vein disease: an unrecognized cause of vein bypass failure. J Vasc Surg. 1992;15:102-110.
  24. Loop FD, Lytle BW, Cosgrove DM, et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med. 1986;314:1-6.
  25. Muneretto C, Negri A, Manfredi J, et al. Safety and usefulness of composite grafts for total arterial myocardial revascularization: a prospective randomized evaluation. J Thorac Cardiovasc Surg. 2003;125:826-835.
  26. Van Son JA, Smedts F, Vincent JG, van Lier HJ, Kubat K. Comparative anatomic studies of various arterial conduits for myocardial revascularization. J Thorac Cardiovasc Surg. 1990;99:703-707.
  27. Barner HB, Barnett MG. Fifteen- to twenty-one-year angiographic assessment of internal thoracic artery as a bypass conduit. Ann Thorac Surg. 1994;57:1526-1528.
  28. Merrilees MJ, Shepphard AJ, Robinson MC. Structural features of saphenous vein and internal thoracic artery endothelium: correlates with susceptibility and resistance to graft atherosclerosis. J Cardiovasc Surg (Torino). 1988;29:639-646.
  29. He GW, Yang CQ, Starr A. Overview of the nature of vasoconstriction in arterial grafts for coronary operations. Ann Thorac Surg. 1995;59:676-683.
  30. Desai ND, Cohen EA, Naylor CD, Fremes SE. A randomized comparison of radialartery and saphenous-vein coronary bypass grafts. N Engl J Med. 2004;351:2302-2309.
  31. Mario Gaudino, Charalambos Antoniades, Umberto Benedetto, Saswata Deb, Antonino Di Franco Circulation. Mechanisms, Consequences, and Prevention of Coronary Graft Failure. Cirkulation. 2017;136:1749-1764. https://doi.org/10.1161/CIRCULATIONAHA.117.027597
  32. Alekyan B. G. Endovaskulyarnyie metody lecheniya u bolnyih IBS s porazheniem osnovnogo stvola levoy koronarnoy arterii / B. G. Alekyan, Yu. I. Buziashvili, A. V. Ctaferov [et al.] // Byulleten NTsSSH im. A. N. Bakuleva RAMN. 7-y Vserossiyskiy s'ezd serdechno-sosudistyih hirurgov. 2001; 199–199.
  33. Belenkov Yu. N. Rentgenomorfologicheskaya harakteristika porazheniya shuntov u bolnyih IBS posle operatsii aortokoronarnogo shuntirovaniya / Yu. N. Belenkov, R. S. Akchurin, A. P. Savchenko, A. A. Shiryaev [et al.] // Kardiologiya. 2001; 1:4–10.
  34. Buziashvili Yu. I. Diastolicheskaya funktsiya levogo zheludochka u bolnyih ishemicheskoy boleznyu serdtsa bez infarkta miokarda v anamneze do i posle operatsii aortokoronarnogo shuntirovaniya / Yu. I. Buziashvili, E. M. Hananashvili, N. M. Burduli [i dr.] // Kardiologiya. 2001;12:62-66].
  35. Nishioka H, Kitamura S, Kameda Y, Taniguchi S, Kawata T, Mizuguchi K. Difference in acetylcholine-induced nitric oxide release of arterial and venous grafts in patients after coronary bypass operations. J Thorac Cardiovasc Surg. 1998;116(3):454-459.
  36. Prasad A, Zalos G, Mincemoyer R, Schenke WH, Quyyumi AA. Nitric oxide activity in arterial and venous bypass grafts [Abstract]. In: Proceedings of the 47th Annual Scientific Session (1191—10). American College of Cardiology. 1998.
  37. Tarr FI, Sasvári M, Tarr M, Rácz R. Evidence of nitric oxide produced by the internal mammary artery graft in venous drainage of the recipient coronary artery. Ann Thorac Surg. 2005;80(5):1728-1731.
  38. Endlich PW, Aires RD, Gonçalves RL, Costa ED, de Paula Arantes Ângelo J, Alves LF, da Silva RF, Rezende BA, Cortes SF, Lemos VS. Neuronal nitric oxide synthase-derived hydrogen peroxide effect in grafts used in human coronary bypass surgery. Clin Sci (Lond). 2017;131(10):1015-1026. https://doi.org/10.1042/CS20160642
  39. ESC/EACTS Guidelines on myocardial revascularization The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2014;35(37):2541-2619.
  40. Ibanez B, James S, Ag S, et al. Acute Myocardial Infarction in patients presenting with ST-segment elevation (Management of) ESC Clinical Practice Guidelines 2017. Eur Heart J. 2017;1-66. https://doi.org/10.1093/eurheartj/ehx393
  41. Garg P, Kamaruddin H, Iqbal J, Wheeldon N. Outcomes of primary percutaneous coronary intervention for patients with previous coronary artery bypass grafting presenting with ST
  42. Nikolsky E, Mehran R, Yu J, et al. Comparison of outcomes of patients with ST-segment elevation myocardial infarction with versus without previous coronary artery bypass grafting (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial). Am J Cardiol. 2013;111(10):1377-1386.
  43. Javaid Iqbal, Chun Shing Kwok, Evangelos Kontopantelis, et al. Outcomes following primary percutaneous coronary intervention in patients with previous coronary artery bypass surgery. Circ Cardiovasc Interv. 2016; 9:e003151.
  44. Welsh RC, Granger CB, Westerhout CM, et al. Prior coronary artery bypass graft patients with st-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. JACC Cardiovasc Interv. 2010;3(3):343-351.
  45. Bench TJ, Parikh PB, Jeremias A, et al. The impact of previous revascularization on clinical outcomes in patients undergoing primary percutaneous coronary intervention. J Invasive Cardiol. 2013;25(4):166-169.
  46. Brilakis ES, Rao SV, Banerjee S, Goldman S, Shunk KA, Holmes DR Jr., Honeycutt E, Roe MT. Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry. JACC Cardiovasc Interv. 2011;4:844-850. https://doi.org/10.1016/j.jcin.2011.03.018
  47. B.G. Alekyan, A.V. Abrosimov. The current situation and future of the percutaneous coronary intervention for acute coronary syndrom in Russian Federation. Complex problems of cardiovascular system. 2013; 1: 5–9].
  48. Gratsiansky N.A. Natsionalnyie rekomendatsii po lecheniyu ostrogo koronarnogo sindroma bez stoykogo pod'ema ST na EKG. Kardiovaskulyarnaya terapiya i profilaktika (Prilozhenie). 2006; 5 (1): 411-40.
  49. A.V. Kontsevaya, A.M. Kalinina, I.E. Koltunov, R.G. Oganov. Socio-economic damage by acute coronary syndrome in Russian Federation. Rational Pharmacother. Card. 2011; 7 (2):158-66.
  50. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics — 2013 update: a report from the American Heart Association. Circulation. 2013;127:6-245.
  51. N.A. Gratsiansky, A.D. Erlikh. The RECORD Acute Coronary Syndromes Registry. Patients and treatment in hospitals. Kardiologiia. 2009; 7: 4–12.
  52. Terkelsen CJ, Lassen JF, Norgaard BL, et al. Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort. Eur Heart J. 2005;26(1):18-26.
  53. Patrono C, Collet J-P, Mueller C, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2015. https://doi.org/10.1093/eurheartj/ehv320
  54. Held C, Tornvall P, Stenestrand U. Effects of revascularization within 14 days of hospital admission due to acute coronary syndrome on 1-year mortality in patients with previous coronary artery bypass graft surgery. Eur Heart J. 2007;28:316-325.
  55. Asrar Ul Haq M, Rudd N, Mian M, et al. Predictors and outcomes of early coronary angiography in patients with prior coronary artery bypass surgery presenting with non-ST elevation myocardial infarction. Open Heart. 2014; 1:e000059.
  56. Morrison DA, Sethi G, Sacks J, et al. Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients. J Am Coll Cardiol. 2002;40:1951-1954.
  57. Brener SJ, Lytle BW, Casserly IP, Ellis SG, Topol EJ, Lauer MS. Predictors of revascularization method and long-term outcome of percutaneous coronary intervention or repeat coronary bypass urgery in patients with multivessel coronary disease and previous coronary bypass surgery. Eur Heart J. 2006;27:413-418.
  58. Cole JH, Jones EL, Craver JM, et al. Outcomes of repeat revascularization in diabetic patients with prior coronary surgery. J Am Coll Cardiol. 2002;40:1968-1975.
  59. Harskamp RE, Beijk MA, Damman P, et al. Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure. J Cardiovasc Med (Hagerstown). 2012.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.